Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine oral solution for urticaria in young children (6 months–2 years)
ChiCTR2300073202Phase 4Not yet recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levocetirizine in acute urticaria and chronic urticaria (CU), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoints: Adverse events and Urticaria symptom score (UAS). Planned start Sep 2023; status: not yet recruiting.
02
Drugs
levocetirizine
03
Conditions
acute urticariachronic urticaria (CU)
Beyond the preview
Go deeper on ChiCTR2300073202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073202.